Selected recent publications:

• London B. Community Corner: Omega 3 oil: a fishy protection for the heart. [Commentary]. Nat Med 2010; 16: In Press.
• McNamara DM, London B. GWAS applied to heart failure: Bigger will be better… eventually. [Editorial]. Circ Cardiovasc Genetics 2010; 3: 226-228.
• Frangiskakis JM, London B. Targeting device therapy: Genomics of Sudden Death. In: McNamara DM, ed. Heart Failure Clinics, Pharmacogenetics in Heart Failure: How it will Shape the Future, 2010; 6: 93-100.
• London B, Frangiskakis JM. Dietary omega-3 fatty acids as a non-pharmacological anti-arrhythmic intervention. In: Billman GE, ed. Novel Therapeutic Targets for Anti-Arrhythmic Drug. New Jersey: John Wiley & Sons, 2010; In Press.
• London B. Understanding cardiac calcium channelopathies. [Editorial]  Circulation 2008; 118: 2221-2222.
• London B. An irregularly irregular inheritance. [Editorial] J Am Col Cardiol 2008; 51: 1090-1091.
• London B. Amiodarone and atrial fibrillation. [Editorial] J Cardiovasc Electrophys 2007; 18: 1321-1322.
• Nilles KN, London B. Knockin animal models of inherited arrhythmogenic diseases: What have we learned from them? [Review] J Cardiovasc Electrophys 2007; 18: 1117-1125.
• London B. A precondition for arrhythmias. [Editorial] J Cardiovasc Electrophys 2007; 18: 100-101.
• London B. CaM Kinase Inhibition: Apply directly to the heart? [Editorial] Circ Res 2006; 99: 1027-1028.
• Salama G, London B. Mouse Models of Long QT Syndrome. [Review]. J Physiol (London) 2007; 578: 43-53.
• London B. Natiuretic peptides and cardiac hypertrophy. [Editorial]. J Am Col Cardiol 2006; 48: 506-507.
• London B. The molecular and genetic basis of arrhythmias. In: Runge MS, Patterson WC, eds. Principles of Molecular Medicine. New Jersey: Humana Press, 2006; 157-165.

CONTACT INFORMATION

Dr. Barry London
Phone: (412) 647-1174
Email: londonb@upmc.edu